Patent · US Active

Compounds, pharmaceutical compositions and uses thereof

US8669271B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Frank Himmelsbach · Mittelbiberach, DE
Matthias Eckhardt · Hannover, DE
Niklas Heine · Eberhardzell, DE
Elke Langkopf · Biberach an der Riß, DE
Bernd Nosse · Biberach an der Riß, DE

Key dates

Filing date	Dec 16, 2011
Grant date	Mar 11, 2014
Priority date	—
Expiry date	Mar 22, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/048
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I,wherein the groups R1, LP, LQ, X1, X2, X3, Ar and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.